4.3 Article

Inhibition of phagocytosis and lysosomal acidification suppresses neurotoxic prion peptide-induced NALP3 inflammasome activation in BV2 microglia

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 260, Issue 1-2, Pages 121-125

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2013.04.016

Keywords

Prion diseases; PrP106-126; NALP3 inflammasome; IL-1 beta

Funding

  1. Natural Science Foundation of China [31001048, 31172293]
  2. Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20100008120002]
  3. Foundation of Chinese Ministry of Science and Technology [2011BAI15B01]
  4. Program for Cheung Kong Scholars and Innovative Research Team in University of China [IRT0866]

Ask authors/readers for more resources

Prion diseases are neurodegenerative disorders characterized by the accumulation of misfolded prion protein. In a previous study, we showed that neurotoxic prion peptide (PrP106-126) induced NALP3 inflammasome activation in mouse primary and immortalized microglia. In the present work, we examined the relevance of phagocytosis and lysosomal acidification to the activation of the NALP3 inflammasome in PrP106-126-stimulated microglia. Our results showed that the inhibition of phagocytosis or lysosomal acidification significantly reduced IL-1 beta and IL-18 production, downregulated NALP3 and ASC expression, and decreased the expression of proinflammatory factors. We concluded that phagocytosis and lysosomal acidification are necessary for PrP106-126-induced NALP3 activation in BV2 cells. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available